Margaret FitzPatrick and Joanne Curley notified the company of their decisions not to stand for re-election at the 2026 Annual Meeting of Stockholders. Vistagen Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for anxiety and stress-related disorders.
